Milena Penkowa
Danish physician and former neuroscientist
Milena Penkowa's AcademicInfluence.com Rankings
Download Badge
Biology Philosophy
Milena Penkowa's Degrees
- PhD Neuroscience University of Copenhagen
- Doctorate Medicine University of Copenhagen
Why Is Milena Penkowa Influential?
(Suggest an Edit or Addition)According to Wikipedia, Milena Penkowa is a Danish neuroscientist who was a professor at the Panum Institute at the University of Copenhagen from 2009–2010. In 2010 she was convicted of fraud and embezzlement of funds from The Danish Society of Neuroscience. In the same year, she was suspended by the University of Copenhagen and consequently resigned her professorship. In 2012, the Danish Committees on Scientific Dishonesty concluded that she had been guilty of scientific misconduct. As of 2020 Penkowa has had nine of her research publications retracted, and four others have received expressions of concern.
Milena Penkowa's Published Works
Published Works
- Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase (2009) (512)
- Supplementation with vitamins C and E inhibits the release of interleukin‐6 from contracting human skeletal muscle (2004) (271)
- Expression of interleukin‐15 in human skeletal muscle – effect of exercise and muscle fibre type composition (2007) (250)
- The role of metallothionein in oncogenesis and cancer prognosis. (2009) (200)
- Strongly compromised inflammatory response to brain injury in interleukin‐6‐deficient mice (1999) (190)
- Immunohistochemical detection of interleukin‐6 in human skeletal muscle fibers following exercise (2003) (170)
- Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin‐6‐deficient mice (2000) (168)
- Astrocytic expression of the Alzheimer's disease β‐secretase (BACE1) is stimulus‐dependent (2003) (154)
- CNS Wound Healing Is Severely Depressed in Metallothionein I- and II-Deficient Mice (1999) (148)
- Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles. (2005) (148)
- Astrocyte-targeted expression of IL-6 protects the CNSagainst a focal brain injury (2003) (147)
- Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures (2001) (145)
- Redefining the Role of Metallothionein within the Injured Brain (2008) (141)
- Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes (2007) (141)
- Metallothionein-1+2 Protect the CNS after a Focal Brain Injury (2002) (140)
- Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid‐induced epileptic seizures (2005) (131)
- Metallothioneins are multipurpose neuroprotectants during brain pathology (2006) (128)
- THIS ARTICLE HAS BEEN RETRACTED Exercise induces interleukin‐8 expression in human skeletal muscle (2005) (119)
- Metallothionein Treatment Reduces Proinflammatory Cytokines IL-6 and TNF-α and Apoptotic Cell Death during Experimental Autoimmune Encephalomyelitis (EAE) (2001) (114)
- Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low‐density lipoprotein receptor family (2007) (97)
- Exercise induces interleukin‐8 receptor (CXCR2) expression in human skeletal muscle (2007) (94)
- Hypoxic Preconditioning Induces Neuroprotective Stanniocalcin-1 in Brain via IL-6 Signaling (2007) (90)
- Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease (2007) (87)
- Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria (2008) (86)
- Astrocyte‐targeted expression of interleukin‐6 protects the central nervous system during neuroglial degeneration induced by 6‐aminonicotinamide (2003) (81)
- Interleukin‐6 receptor expression in contracting human skeletal muscle: regulating role of IL‐6 (2005) (80)
- Retracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis (2000) (79)
- Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains. (1999) (76)
- Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis (2001) (76)
- Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice (2006) (75)
- Retracted: Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis (2003) (73)
- Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury (2005) (70)
- The Balance between Life and Death of Cells: Roles of Metallothioneins (2006) (69)
- Metallothionein‐I+II in neuroprotection (2009) (67)
- Metallothionein-1+2 Deficiency Increases Brain Pathology in Transgenic Mice with Astrocyte-Targeted Expression of Interleukin 6 (2002) (65)
- Impaired Inflammatory Response to Glial Cell Death in Genetically Metallothionein-I- and -II-Deficient Mice (1999) (61)
- Expression of Metallothionein-I, -II, and -III in Alzheimer Disease and Animal Models of Neuroinflammation (2006) (61)
- The role of metallothionein II in neuronal differentiation and survival (2003) (59)
- In vivo expression of neuroglobin in reactive astrocytes during neuropathology in murine models of traumatic brain injury, cerebral malaria, and autoimmune encephalitis (2010) (59)
- Metallothioneins I and II: neuroprotective significance during CNS pathology. (2007) (58)
- Metallothionein-I and -III expression in animal models of Alzheimer disease (2006) (57)
- Zinc or copper deficiency-induced impaired inflammatory response to brain trauma may be caused by the concomitant metallothionein changes. (2001) (56)
- Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6‐aminonicotinamide (2002) (55)
- Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis (2001) (52)
- Metallothionein expression in the central nervous system of multiple sclerosis patients (2003) (52)
- Brain response to traumatic brain injury in wild‐type and interleukin‐6 knockout mice: a microarray analysis (2005) (52)
- Role of metallothionein-III following central nervous system damage (2003) (51)
- IL-6 Deficiency Leads to Reduced Metallothionein-I+II Expression and Increased Oxidative Stress in the Brain Stem after 6-Aminonicotinamide Treatment (2000) (49)
- Novel roles for metallothionein‐I + II (MT‐I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: Insights from global gene expression profiling in wild‐type and MT‐I + II knockout mice (2006) (48)
- Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury (2008) (46)
- Metallothionein expression and oxidative stress in the brain. (2002) (46)
- Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis (2003) (46)
- Distribution of metallothionein I + II and vesicular zinc in the developing central nervous system: Correlative study in the rat (1999) (44)
- Metallothionein‐I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte‐targeted interleukin‐6 expression (2003) (43)
- Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury (2006) (42)
- Hydrocephalus induces dynamic spatiotemporal regulation of aquaporin-4 expression in the rat brain (2010) (41)
- Metallothionein‐I Overexpression Decreases Brain Pathology in Transgenic Mice with Astrocyte‐Targeted Expression of Interleukin‐6 (2003) (41)
- Chemical Blocking of Zinc Ions in CNS Increases Neuronal Damage Following Traumatic Brain Injury (TBI) in Mice (2010) (40)
- The mRNA expression profile of metabolic genes relative to MHC isoform pattern in human skeletal muscles. (2006) (40)
- Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis (2005) (39)
- Effect of astrocyte‐targeted production of IL‐6 on traumatic brain injury and its impact on the cortical transcriptome (2008) (39)
- Increased astrocytic expression of metallothioneins I+II in brainstem of adult rats treated with 6-aminonicotinamide (1997) (38)
- Metallothioneins Are Upregulated in Symptomatic Mice with Astrocyte-Targeted Expression of Tumor Necrosis Factor-α (2000) (38)
- Cell death in the injured brain: roles of metallothioneins. (2009) (36)
- Exercise‐induced metallothionein expression in human skeletal muscle fibres (2005) (36)
- Role of metallothioneins in peripheral nerve function and regeneration (2003) (35)
- Treatment with Anti-interferon-γ Monoclonal Antibodies Modifies Experimental Autoimmune Encephalomyelitis in Interferon-γ Receptor Knockout Mice (2001) (35)
- Human immunodeficiency virus‐associated malignant lymphoma in eastern Denmark diagnosed from 1990 to 1996: clinical features, histopathology, and association with Epstein‐Barr virus and human herpesvirus‐8 (2000) (32)
- Astrocyte-Targeted Expression of Interleukin-3 and Interferon-α Causes Region-Specific Changes in Metallothionein Expression in the Brain (2001) (31)
- Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6‐aminonicotinamide (2004) (30)
- Metallic gold reduces TNFα expression, oxidative DNA damage and pro-apoptotic signals after experimental brain injury (2009) (29)
- Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 2005;54:3089–3094 (2005) (29)
- Matrix metalloproteinases during and outside of migraine attacks without aura (2010) (29)
- Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase (2015) (27)
- Diverging mechanisms for TNF‐α receptors in normal mouse brains and in functional recovery after injury: From gene to behavior (2007) (27)
- Altered expression of metallothionein-I and -II and their receptor megalin in inherited photoreceptor degeneration. (2010) (26)
- Intraneuronal signaling pathways of metallothionein (2009) (25)
- Structure and function of vertebrate metallothioneins (2009) (24)
- Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury. (2009) (21)
- RETRACTED: M-CSF Deficiency Leads to Reduced Metallothioneins I and II Expression and Increased Tissue Damage in the Brain Stem after 6-Aminonicotinamide Treatment (2002) (20)
- Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution (2006) (19)
- Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice. (2001) (19)
- Metallothionein I + II expression and roles during neuropathology in the CNS. (2006) (16)
- Interferon-γ Regulates Oxidative Stress during Experimental Autoimmune Encephalomyelitis (2002) (16)
- The renal metallothionein expression profile is altered in human lupus nephritis (2008) (15)
- METALLOTHIONEIN EXPRESSION AND ROLES IN THE CENTRAL NERVOUS SYSTEM (2002) (15)
- Metallic silver fragments cause massive tissue loss in the mouse brain. (2011) (14)
- Renal cell apoptosis in human lupus nephritis: a histological study (2009) (14)
- Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis (2012) (13)
- Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis. (2002) (13)
- Metallothionein-I + II and receptor megalin are altered in relation to oxidative stress in cerebral lymphomas (2010) (13)
- Analysis of the Cerebral Transcriptome in Mice Subjected to Traumatic Brain Injury: Importance of IL-6 (2007) (12)
- Bio-released gold ions modulate expression of neuroprotective and hematopoietic factors after brain injury (2010) (12)
- Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model. (2011) (12)
- Hematopoietic growth factors for the treatment of myelodysplastic syndromes. (1998) (10)
- Metallothionein as a useful marker in Hodgkin lymphoma subclassification (2009) (9)
- The synthetic NCAM-derived peptide, FGL, modulates the transcriptional response to traumatic brain injury (2008) (8)
- Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 2005;54:3089–3094 (2005) (5)
- Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (2016) (4)
- Retraction: Exercise induces interleukin‐8 expression in human skeletal muscle (2011) (4)
- Meningococcal disease and future drug targets. (2011) (3)
- Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase (2012) (3)
- Erratum to: Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease (2011) (2)
- Retraction Note to: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (2020) (2)
- Immune and Inflammatory Responses in the Central Nervous System: Modulation by Astrocytes (2008) (2)
- Cell proliferation index predicts relapse of brain metastases in non-irradiated patients (2008) (2)
- [AIDS-related non-Hodgkin lymphomas. Clinical picture and prognosis]. (1998) (1)
- From bone marrow to brain: stem cells in neuroprotection, plasticity, and neuroregeneration (2011) (1)
- [Inflammation and neuroregeneration--professor accession]. (2010) (0)
- Retraction: Exercise‐induced metallothionein expression in human skeletal muscle fibres (2011) (0)
- Retraction (2014) (0)
- RedefiningtheRoleofMetallothioneinwithintheInjuredBrain EXTRACELLULARMETALLOTHIONEINSPLAYANIMPORTANTROLEINTHE ASTROCYTE-NEURONRESPONSETOINJURY * (2008) (0)
- [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock]. (2008) (0)
- Research Article Metallothionein expression in the central nervous system of multiple sclerosis patients (2003) (0)
- Retraction notice to “M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment” Exp Neurol 176 (2002) 308–321 (2013) (0)
- Retraction (2014) (0)
- Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis (2012) (0)
- Roles of NGF-derived Peptides in Neuritogenesis And Neuronal Survival (2007) (0)
This paper list is powered by the following services:
Other Resources About Milena Penkowa
What Schools Are Affiliated With Milena Penkowa?
Milena Penkowa is affiliated with the following schools: